Key result
Bilateral cardiac sympathetic denervation effectively suppressed treatment-resistant ventricular tachycardia in patients with ischemic cardiomyopathy.
Why the study?
Recent studies have shown cardiac sympathetic denervation is effective for refractory ventricular tachyarrhythmia in structural heart disease, prompting evaluation of bilateral cardiac sympathetic denervation in ischemic cardiomyopathy.
Does bilateral cardiac sympathetic denervation suppress treatment-resistant ventricular tachycardia in patients with ischemic cardiomyopathy?
Does bilateral cardiac sympathetic denervation suppress treatment-resistant ventricular tachycardia in patients with ischemic cardiomyopathy?
Bilateral cardiac sympathetic denervation may be an effective strategy for suppressing treatment-resistant ventricular tachycardia in patients with ischemic cardiomyopathy.
Hypothesis-generating for bilateral denervation in refractory ischemic VT; larger prospective trials needed before clinical adoption.
Recent studies have shown that cardiac sympathetic denervation (CSD) is effective in the treatment of refractory ventricular tachyarrhythmia in patients with structural heart disease. This case report aimed to highlight the effect of bilateral CSD in suppressing treatment-resistant ventricular tachycardia in patients with ischemic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Miki et al. (2020) studied this question. Bilateral cardiac sympathetic denervation effectively suppressed treatment-resistant ventricular tachycardia in patients with ischemic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: